본문 바로가기
bar_progress

Text Size

Close

The Past 'HLB' Has Returned! For Those Who Missed It Then, Now Is Your Chance!!

Those who applied for hit the daily limit in just one day! Achieved 31% profit!

Congratulations to everyone who signed up for the free trial. ^^


※ For those who missed the “COVID-19 treatment” opportunity, no worries. We are launching another big move.

※ Finally starting. HLB (028300) follow-up stock hits the daily limit on Tuesday. ※


▶▶ On August 18, starting big with the ‘daily limit’ for HLB! Related to ‘ㅇㅇㅇㅇㅇ’! ▶ Free trial application ◀


HLB has received IND approval from the Korean Ministry of Food and Drug Safety for the global Phase 3 clinical trial of the first-line liver cancer treatment combining rivoceranib and calelelizumab, jointly conducted with China’s Hansoh Pharmaceutical and Elevation!

The global Phase 3 clinical trial for the first-line liver cancer treatment involves a total of 510 subjects and is being conducted in China, the United States, Europe, Taiwan, and now Korea has been added. In Korea, the trial will be conducted at 10 locations including Seoul Asan Medical Center, Samsung Seoul Hospital, and Seoul National University Hospital!



▶▶ Heading straight ‘up’ on Tuesday. Moving fast. HLB daily limit development! Related beneficiary stocks! Don’t miss out [Apply now for ‘HLB daily limit’ related stocks]


“It was just too difficult to trade stocks alone.” I asked acquaintances for advice here and there, but I never made a proper profit even once. So I decided to get help from an expert and first applied for the 3-day free trial! Wow! Experts really are different. I am still receiving the service now, and looking back, I think it was a great decision. Thank you very much.

(VIP office worker Kim Minji, 46 years old, member)


Now think of this as your last chance. If you miss this opportunity, you should quit.

Exactly on “August 18” it will explode! Don’t miss out and regret it, buy at least 1 million KRW worth!



▶▶ “August 18 daily limit” offered only until today and then closed. [Receive ‘HLB daily limit’ related stocks!] ▶ Receive stocks ◀


[AI recent daily limit hits]

*20.08.13 HLB (028300) daily limit hit!

*20.08.12 Ilsin Bio (068330) daily limit hit!

*20.08.11 Korea Biogen (318000) daily limit hit!

*20.08.10 CIS (222080) daily limit hit!

*20.08.07 Seoyeon Top Metal (019770) daily limit hit!

*20.08.06 Hyosung O&B (097870) daily limit hit!

*20.08.05 DA Technology (196490) daily limit hit!

*20.08.04 Kainos Med (284620) daily limit hit!

*20.08.03 Access Bio (950130) daily limit hit!

*20.07.31 BioSmart (038460) daily limit hit!

*20.07.30 Simtek (222800) daily limit hit!

*20.07.29 Bitsro Tech (042370) daily limit hit!

*20.07.28 Hanmi Science (008930) daily limit hit!

*20.07.27 LTC (170920) daily limit hit!

*20.07.24 Kyungdong Pharmaceutical (011040) daily limit hit!

*20.07.23 Labgenomics (084650) daily limit hit!

*20.07.22 Ilsin Bio (068330) daily limit hit!

*20.07.21 Hwail Pharmaceutical (061250) daily limit hit!

*20.07.20 Newbotec (060260) daily limit hit!

*20.07.17 Euratech (048430) daily limit hit!

*20.07.16 Dong-A Hwasung (041930) daily limit hit!


▶▶ Only 10 spots available. “Tuesday daily limit”! ▶ Get it now ◀


※ First-come, first-served for 10 people! Both early and late rounds are over. The hero of the final injury time winning goal ※


[Today’s stocks of interest]

#HLB #Aluco #Jeongdawoon #CIS #IlsinBio


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top